Medicare could negatively affect Abbott's pricing in the long run

Although new Medicare reform has covered Humira, which will boost sales, it could negatively affect Abbott's pricing in the long run. As Medicare continues to be reformed, more prescription drugs will be covered. If Abbott is forced to lower their prices, it will hurt the revenues in the pharmaceutical division.